Transaction · 0001522780-26-000007

Kaye Edward M. Md

Kaye Edward M. MD, DIR, reported an open-market or private sale at Stoke Therapeutics, Inc. involving 11930.000000 shares for an estimated $381845.90. Reported holdings after the transaction were 125194.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
STOKStoke Therapeutics, Inc.
Trade date
Aug 18, 2026
Filing date
Aug 19, 2026
View on SEC Insider profile
Estimated value-$381kShares × reported price
Shares traded11.9k$32.01 per share
Holdings after125kDirect
% of reported position traded8.7%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 137,124 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

STOK price since this filing

Daily closing prices, with the filing date and available return windows
STOK · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -12.0%1w ago -0.2%1d ago -2.7%
Returns since7d +0.2%30d -13.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001522780-26-000007
Common Stock
Transaction date
Aug 18, 2026
Filed Aug 19, 2026, 12:28 AM · 1d delay
Shares
11,930 sh
$32.01 per share
Estimated value
-$381k
Computed from shares × price
Holdings after
125,194 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertake…

  3. F3

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive.

  4. F4

    Each performance stock unit represents a right to receive one share of the Issuer's common stock.

  5. F5

    Achievement of this performance stock unit award was certified on August 14, 2025. Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on A…

Original filing · 0001522780-26-000007
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

STOK